-
公开(公告)号：KR101384497B1
公开(公告)日：2014-04-10
申请号：KR1020110029587
申请日：2011-03-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/484 , A61K36/48 , A61P25/28 , A61P25/00
CPC classification number: A61K31/35 , A61K31/366 , A61K36/48
Abstract: 본 발명은 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 유효 성분으로 포함하여 지방 세포의 분화를 억제하며, 신체 면역을 증진시키고, 독성 물질을 해독하며, 퇴행성 신경 장애를 예방 또는 개선하는 조성물을 개시한다.
Abstract translation: 本发明涉及一种组合物，其包含作为活性成分的香草雌酚或含有香豆素的豆提取物，其中脂肪细胞分化被抑制，身体的免疫系统得到改善，有毒物质被清除，并且可以预防或改善神经变性疾病。
-
公开(公告)号：KR101326979B1
公开(公告)日：2013-11-14
申请号：KR1020110009649
申请日：2011-01-31
Applicant: (주)아모레퍼시픽
CPC classification number: C12P17/181
Abstract: 본 발명은 콩을 발아시키는 발아 공정; 및 콩을 발효시키는 발효 공정을 포함하는 쿠메스트롤 생산 방법과 상기 생산 방법에 의해 생산된 쿠메스트롤을 개시한다.
-
公开(公告)号：KR1020130044712A
公开(公告)日：2013-05-03
申请号：KR1020110108914
申请日：2011-10-24
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol for treating eye diseases is provided to normalize the function of mitochondria and to prevent or treat eye diseases especially age-related eye diseases. CONSTITUTION: A composition for preventing or treating eye diseases contains 1-80 wt% of syringaresinol. The eye diseases are selected from the group consisting of macular degeneration, uveitis, glaucoma, diabetic retinopathy, and cataract. Syringaresinol is contained in extracts prepared using one or more selected among linseed, Phellodendron amurense Ruprecht, Acanthopanax senticosus, sesame seeds, and ginseng fruits. The composition enhances SIRT 1 expression and mitochondria synthesis. [Reference numerals] (AA) SIRT1 protein expression
Abstract translation: 目的：提供一种含有用于治疗眼睛疾病的丁香ares醇的组合物，用于标准化线粒体的功能，并预防或治疗眼睛疾病，特别是年龄相关的眼睛疾病。 构成：用于预防或治疗眼睛疾病的组合物含有1-80重量％的丁香胺。 眼疾病选自黄斑变性，葡萄膜炎，青光眼，糖尿病性视网膜病变和白内障。 使用一种或多种选自亚麻籽，Phellodendron amurense Ruprecht，Acanthopanax senticosus，芝麻和人参果实中制备的提取物中含有Syringaresinol。 该组合物增强SIRT1表达和线粒体合成。 （AA）SIRT1蛋白表达
-
84.发明公开차나무 뿌리 유래 사포닌을 함유하는 계면활성제 및 이를 포함하는 세정제 조성물 审中-实审含有CAMONIA SINENSIS的根提取的含有SAPONIN的表面活性剂和包含其的液体清洁组合物
公开(公告)号：KR1020130035324A
公开(公告)日：2013-04-09
申请号：KR1020110099526
申请日：2011-09-30
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A surfactant containing a saponin extract obtained from the root of camellia sinensis is provided to have an excellent bubble generating function without the stimulation on skin and scalp, and to have excellent cleaning force. CONSTITUTION: A surfactant containing a saponin extract obtained from the root of camellia sinensis comprises saponin. The saponin is triterpenoid saponin. The triterpenoid saponin is one or more compounds selected from chemical formula 1-10. A liquid cleansing composition comprises 0.1-20wt% of the surfactant based on the total weight of the composition. [Reference numerals] (AA) Saponin extract obtained from the root of camellia sinensis R1; (BB) Saponin extract obtained from the root of camellia sinensis R2; (CC) Saponin extract obtained from the root of camellia sinensis R3; (DD) Saponin extract obtained from the root of camellia sinensis R4; (EE) Saponin extract obtained from the root of camellia sinensis R5; (FF) Saponin extract obtained from the root of camellia sinensis R6; (GG) Saponin extract obtained from the root of camellia sinensis R7; (HH) Saponin extract obtained from the root of camellia sinensis R8; (II) Saponin extract obtained from the root of camellia sinensis R9; (JJ) Saponin extract obtained from the root of camellia sinensis R10;
Abstract translation: 目的：提供从山茶根获得的含有皂苷提取物的表面活性剂，具有优异的发泡功能，无需刺激皮肤和头皮，并具有优异的清洁力。 构成：含有从山茶根获得的皂角苷提取物的表面活性剂含有皂苷。 皂苷是三萜皂苷。 三萜皂苷是选自化学式1-10的一种或多种化合物。 基于组合物的总重量，液体清洁组合物包含0.1-20重量％的表面活性剂。 [参考数字]（AA）从山茶根中获得的皂苷提取物; （BB）从山茶根R2获得的皂角苷提取物; （CC）从山茶根中获得的皂角苷提取物; （DD）从山茶根中获得的皂苷提取物R4; （EE）从山茶的根部获得的皂苷提取物R5; （FF）从山茶根R6获得的皂苷提取物; （GG）从山茶根中获得的皂苷提取物R7; （HH）从山茶根中获得的皂角苷提取物R8; （二）从山茶根中获得的皂苷提取物R9; （JJ）从山茶根R10获得的皂苷提取物;
-
公开(公告)号：KR1020110110054A
公开(公告)日：2011-10-06
申请号：KR1020110029587
申请日：2011-03-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/484 , A61K36/48 , A61P25/28 , A61P25/00
CPC classification number: A61K31/35 , A61K31/366 , A61K36/48
Abstract: 본 발명은 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 유효 성분으로 포함하여 지방 세포의 분화를 억제하며, 신체 면역을 증진시키고, 독성 물질을 해독하며, 퇴행성 신경 장애를 예방 또는 개선하는 조성물을 개시한다.
Abstract translation: 本发明涉及一种组合物，其包含作为活性成分的香草雌酚或含有香豆素的豆提取物，其中脂肪细胞分化被抑制，身体的免疫系统得到改善，有毒物质被清除，并且可以预防或改善神经变性疾病。
-
Patent Agency Ranking
公开(公告)号：KR1020110060140A
公开(公告)日：2011-06-08
申请号：KR1020090116640
申请日：2009-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/481 , A61P21/00 , A61P29/00 , A23L1/30
CPC classification number: A61K36/481 , A23L33/105 , A23V2002/00 , A23V2250/21
Abstract: PURPOSE: A composition containing Astragali Radix extract is provided to promote the expression of PGC1-alpha(peroxisome proliferator-activated receptor gamma coactivator 1-alpha). CONSTITUTION: A composition for promoting body energy consumption and muscle metabolism and strengthen muscle contains 1-80 weight% of Astragali Radix extract as an active ingredient. The composition is a pharmaceutical composition or food composition. The Astragali Radix extract is isolated using leaves, stems, and roots of Astragali Radix. The Astragali Radix extract is prepared by extracting Astragali Radix in 10 time volume of distilled water for three hours, filtering with a Whatman No.1 filter, and freeze-drying at -70°C.
Abstract translation: 目的：提供含有黄芪提取物的组合物，以促进PGC1-α（过氧化物酶体增殖物激活受体γ共激活因子1-α）的表达。 构成：用于促进身体能量消耗和肌肉代谢并增强肌肉的组合物含有1-80重量％的黄芪提取物作为活性成分。 组合物是药物组合物或食物组合物。 黄芪提取物使用黄芪的叶，茎和根进行分离。 黄芪提取物通过在10倍体积的蒸馏水中提取黄芪提取物三小时，用Whatman 1号滤器过滤，并在-70℃下冷冻干燥制备。
-
公开(公告)号：KR1020100134381A
公开(公告)日：2010-12-23
申请号：KR1020090052982
申请日：2009-06-15
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for promoting the alcoholysis inside a human body is provided to use a post-heating fermented tea extract as an active ingredient for reducing hangover. CONSTITUTION: A composition for promoting the alcoholysis contains a post-heating fermented tea extract using non-pathogenic microorganisms as an active ingredient. The non-pathogenic microorganisms are selected from the group consisting of yeast, lactobacillus, saccharomyces genus, bacillus genus, and aspergillus genus. The composition promotes the activity of alcohol dehydrogenase and acetaldehyde dehydrogenase.
Abstract translation: 目的：提供一种用于促进人体内醇解的组合物，使用后加热发酵茶提取物作为减少宿醉的活性成分。 构成：用于促进醇解的组合物包含使用非致病微生物作为活性成分的后加热发酵茶提取物。 非病原微生物选自酵母，乳杆菌属，酵母属，芽孢杆菌属和曲霉属。 该组合物促进醇脱氢酶和乙醛脱氢酶的活性。
-
公开(公告)号：KR1020100127728A
公开(公告)日：2010-12-06
申请号：KR1020100049181
申请日：2010-05-26
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/48 , A23L2/52 , A23L33/105 , A61K2236/333 , A23V2200/30
Abstract: PURPOSE: A composition containing soybean extract isolated with low alcohol is provided to improve blood circulation and to treat obesity, diabetes, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains soybean extract isolating with 1-7% of C1-5 alcohol or fraction. The C1-5 alcohol is methanol, ethanol, isopropylalcohol, n-propylalcohol, n-butanol or isobutanol. The soybean extract or fraction contains adenosine. The fraction is an ethylacetate or butanol fraction. The composition suppresses thrombosis or cholesterol generation.
Abstract translation: 目的：提供含有用低分子量分离的大豆提取物的组合物，以改善血液循环和治疗肥胖症，糖尿病和高脂血症。 构成：用于改善血液循环的组合物含有用1-7％的C1-5醇或级分分离的大豆提取物。 C 1-5醇是甲醇，乙醇，异丙醇，正丙醇，正丁醇或异丁醇。 大豆提取物或级分含有腺苷。 馏分是乙酸乙酯或丁醇馏分。 该组合物抑制血栓形成或胆固醇的产生。
-
公开(公告)号：KR1020100127420A
公开(公告)日：2010-12-06
申请号：KR1020090045858
申请日：2009-05-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/79 , A61K36/896 , A61K36/258
CPC classification number: A61K36/79 , A61K36/258 , A61K36/896 , A61K2300/00
Abstract: PURPOSE: A ginseng complex composition which enhances the bioavailability of saponin is provided to improve the physiological activity of ginseng saponin. CONSTITUTION: A ginseng complex composition for enhancing the bioavailability of saponiin contains Schisandra chinensis extract or Liriope platyphylla extract and ginseng extract containing saponin. The ginseng extract is ginseng fruit extract. The saponin is ginsenoside Re. A composition for enhancing the bioavailability of saponin contains Schisandra chinensis extract or Liriope platyphylla extract as an active ingredient.
Abstract translation: 目的：提高人参皂苷生理活性，提高皂角苷的生物利用度。 构成：提高saponiin生物利用度的人参复合物组合物含有五味子提取物或Liriope platyphylla提取物和含有皂苷的人参提取物。 人参提取物是人参水果提取物。 皂苷是人参皂甙Re。 用于提高皂角苷生物利用度的组合物含有五味子提取物或Liriope platyphylla提取物作为活性成分。
-
公开(公告)号：KR100989834B1
公开(公告)日：2010-10-29
申请号：KR1020060119449
申请日：2006-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K31/722 , C08B37/00
CPC classification number: A61K31/722
Abstract: 본 발명은 키토올리고당을 유효성분으로 함유하는 피로 개선용 조성물 및 AMPK 활성 촉진용 조성물에 관한 것으로, 보다 상세하게는 키토올리고당을 함유하여 AMPK 및 지방대사 관련 효소에 영향을 줌으로써 간세포에서의 에너지 대사를 촉진시키는 조성물에 관한 것이다.
키토올리고당, AMPK, 활성, 촉진, 간세포, 에너지대사
-
-
-
-
-
-
-
-
-
Search Results
187
records
(took 0.033 seconds)
